Steven Cohen Repligen Corp Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Repligen Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 918,623 shares of RGEN stock, worth $119 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
918,623
Previous 324,434
183.15%
Holding current value
$119 Million
Previous $48.3 Million
173.86%
% of portfolio
0.31%
Previous 0.13%
Shares
25 transactions
Others Institutions Holding RGEN
# of Institutions
486Shares Held
56.5MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$984 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$928 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$663 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$220 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$201 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.21B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....